CollPlant Biotechnologies Ltd.
CLGN
$1.90
$0.3724.18%
NASDAQ
| 06/30/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -- | -16.61M | -17.42M | -17.47M | |
| Total Depreciation and Amortization | -- | 1.04M | 1.08M | 1.10M | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | 1.85M | 1.86M | 2.03M | |
| Change in Net Operating Assets | -- | -372.00K | 1.51M | 11.60M | |
| Cash from Operations | -- | -14.09M | -12.97M | -2.75M | |
| Capital Expenditure | -- | -483.00K | -653.00K | -756.00K | |
| Sale of Property, Plant, and Equipment | -- | 1.00K | 68.00K | 68.00K | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | -57.00K | -268.00K | -268.00K | |
| Cash from Investing | -- | -539.00K | -853.00K | -956.00K | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | -- | 9.00K | 9.00K | 225.00K | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | -- | 9.00K | 9.00K | 225.00K | |
| Foreign Exchange rate Adjustments | -- | -142.00K | -3.00K | -176.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -14.77M | -13.82M | -3.66M | |